Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

BACKGROUND: Panitumumab in combination with chemotherapy was evaluated in two pivotal clinical trials in first- and second-line treatment of metastatic colorectal cancer (mCRC), respectively. This analysis compared the health-related quality of life (HRQoL) of patients with or without panitumumab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, L, Zhao, Z, Barber, B, Zhou, X, Peeters, M, Zhang, J, Xu, F, Wiezorek, J, Douillard, J-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242525/
https://www.ncbi.nlm.nih.gov/pubmed/21989186
http://dx.doi.org/10.1038/bjc.2011.409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242525/
https://www.ncbi.nlm.nih.gov/pubmed/21989186
http://dx.doi.org/10.1038/bjc.2011.409

Ejemplares similares